US SMid Biotech Analyst Rama and US Major & Specialty Pharmaceuticals Analyst Schott, along with Dr. Charles Ryan, Genitourinary Medical Oncologist at Memorial Sloan Kettering Cancer Center discuss the evolving treatment landscape in prostate cancer (relevant companies PFE ORIC JNJ) on an Analyst/Industry conference call to be held on June 12 at 2 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- M&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion Deal
- M&A News: BioNTech Snaps Up CureVac in $1.25B Deal to Supercharge Cancer Pipeline
- RFK Jr. names eight members to vaccine panel, WSJ reports
- RFK Jr. names new CDC vaccine advisory panel picks, STAT reports
- Mixed options sentiment in Pfizer with shares up 0.97%